Test Price
1,200 AEDโ Home Collection Available
Extended Newborn Screening Panel โ 1,200 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance on result interpretation by a DHA-licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Extended Newborn Screening (Dried Blood Spot โ DBS) utilizes tandem mass spectrometry (LC-MS/MS) and advanced immunoassays to detect over 50 inborn errors of metabolism from a single heel prick, ensuring early intervention in line with the UAEโs mandatory screening program. All testing is performed at DNA Labs UAE under strict ISO 9001:2015 quality management.
| Feature | DNA Labs UAE Extended Panel | Standard Public Screening (UAE Mandatory Panel) |
|---|---|---|
| Methodology | Tandem Mass Spectrometry (LC-MS/MS) + FEIA + Specialized Immunoassays | Basic Fluorometric / ELISA (limited panel) |
| Conditions Detected | 50+ inborn errors: metabolic, endocrine, hemoglobinopathies | ~10 disorders (mandatory UAE list only) |
| Diagnostic Sensitivity | 99.9% | ~95% |
| Turnaround Time | Next day (samples accepted Mon/Wed/Fri by 9 AM) | 5โ7 working days |
| Sample Collection | Cold-chain home collection, heel prick DBS on LPL filter paper | Hospital visit only, ambient transport |
| Post-Test Guidance | Included telephonic consultation with specialist | Minimal / Self-referral |
Physician Insight & Safety Protocols
"As a medical geneticist, I understand the deep anxiety parents feel during newborn screening. This extended panel offers a comprehensive safety net, but an abnormal result must always be followed by confirmatory diagnostic testing and prompt specialist consultation. Early detection saves livesโplease act quickly if a flag appears."
โ Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
โ Medication Safety Notice
Do not discontinue any prescribed medication for your baby without consulting your doctor.
Emergency Exclusion Criteria & Red Flags
โ Exclusion Criteria
- Infants with severe illness or extremely low birth weight (<1000 g) may require modified sampling protocols.
- If the neonate is on total parenteral nutrition (TPN) or antibiotics, draw the sample before administration or after clearance to avoid transient false elevations.
- Emergency Warning Signs: Lethargy, seizures, poor feeding, persistent vomiting, or hypotonia โ proceed to the nearest ER immediately, regardless of screening results.
Patient FAQ & Clinical Guidance
1. What conditions does the extended newborn screening panel detect?
The panel detects over 50 inborn errors of metabolism, endocrine disorders, and hemoglobinopathies from a dried blood spot sample.
2. How is the sample collected for my newborn, and is it painful?
A quick heel prick collects a few drops of blood onto filter paper, causing minimal discomfort. The procedure is performed at your home by our trained phlebotomist.
3. What should I do if my babyโs screening result is abnormal?
An abnormal result indicates a possible metabolic disorder, warranting urgent confirmatory testing and immediate consultation with a medical geneticist. Our post-test telephonic guidance will assist you in taking the next steps.
UAE Regulatory & Data Privacy Adherence
Legal & Privacy Framework
All clinical data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Extended Newborn Screening Panel (Dried Blood Spot) |
| Price (AED) | 1,200 |
| Turnaround Time | Next day (samples accepted Monday, Wednesday, Friday by 9 AM) |
| Sample Type / Matrix | Dried Blood Spot (heel prick) |
| Methodology Used | Tandem Mass Spectrometry (LC-MS/MS) + Fluoroenzyme Immunoassay (FEIA) |
| ICD-10-CM Code | Z13.2 |
| LOINC Code | 73793-4 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians